Psychiatry investigation

  • 제14권2호
  • /
  • Pages.111-117
  • /
  • 2017
  • /
  • 1738-3684(pISSN)
  • /
  • 1976-3026(eISSN)
대한신경정신의학회 (Korean Neuropsychiatric Association)
권호 표지
DOI QR코드

DOI QR Code

Factors Related to Noncompliance in Screening and Tracking Mild Cognitive Impairment Patients in a Single Community

  • 투고 : 2015.06.18
  • 심사 : 2016.03.30
  • 발행 : 2017.03.25
⟨ 이전 논문 다음 논문 ⟩

초록

Objective We assessed the cumulative conversion rates (CCR) from minor cognitive impairment (MCI) to dementia among individuals who failed to participate in annual screening for dementia. Additionally, we analyzed the reasons for failing to receive follow-up screening in order to develop better strategies for improving follow-up screening rates. Methods We contacted MCI patients who had not visited the Dongdaemun-gu Center for Dementia for annual screening during the year following their registration. We compared the CCR from MCI to dementia in the following two groups: subjects registered as having MCI in the Dongdaemun-gu Center for Dementia database and subjects who failed to revisit the center, but who participated in a screening test for dementia after being contacted. The latter participants completed a questionnaire asking reasons for not previously visiting for follow-up screening. Results The final diagnoses of the 188 subjects who revisited the center only after contact were 19.1% normal, 64.9% MCI and 16.0% dementia. The final diagnoses of the 449 subjects in the Dongdaemun-gu Center for Dementia database were 25.6% normal, 46.1% MCI and 28.3% dementia. The CCR of the revisit-after-contact group was much lower than anticipated. The leading cause for noncompliance was "no need for tests" at 28.2%, followed by "other reasons" at 23.9%, and "I forgot the appointment date" at 19.7%. Conclusion Considering the low dementia detection rate of the group who revisited only after contact and the reasons they gave for noncompliance, there appears to be a need for ongoing outreach and education regarding the course and prognosis of MCI.

키워드

참고문헌

  1. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240-246. https://doi.org/10.1111/j.1365-2796.2004.01380.x
  2. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack Jr CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263-269. https://doi.org/10.1016/j.jalz.2011.03.005
  3. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308. https://doi.org/10.1001/archneur.56.3.303
  4. Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia-- meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 2009;119:252-265. https://doi.org/10.1111/j.1600-0447.2008.01326.x
  5. Petersen R, Stevens J, Ganguli M, Tangalos E, Cummings J, DeKosky S. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1133-1142. https://doi.org/10.1212/WNL.56.9.1133
  6. Lin JS, O'Connor E, Rossom RC, Perdue LA, Burda BU, Thompson M, et al. Screening for Cognitive Impairment in Older Adults: An Evidence Update for the US Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Nov. Report No.: 14-05198-EF-1.
  7. Gearing M, Mirra S, Hedreen J, Sumi S, Hansen L, Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 1995;45:461-466. https://doi.org/10.1212/WNL.45.3.461
  8. Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Kim JH, et al. Development of the Korean Version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci 2002;57:47-53. https://doi.org/10.1093/geronb/57.1.P47
  9. Aretouli E, Tsilidis KK, Brandt J. Four-year outcome of mild cognitive impairment: the contribution of executive dysfunction. Neuropsychology 2013;27:95-106. https://doi.org/10.1037/a0030481
  10. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183-194. https://doi.org/10.1111/j.1365-2796.2004.01388.x
  11. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:270-279. https://doi.org/10.1016/j.jalz.2011.03.008
  12. Kim H, Park K, Kim S. Survey of dementia awareness and needs in Seongdong-gu regional center for dementia. Dement Neurocogn Disord 2008;7:52-63.
  13. Vogel A, Stokholm J, Gade A, Andersen BB, Hejl AM, Waldemar G. Awareness of deficits in mild cognitive impairment and Alzheimer's disease: do MCI patients have impaired insight? Dement Geriatr Cogn Disord 2004;17:181-187. https://doi.org/10.1159/000076354
  14. Vogel A, Hasselbalch SG, Gade A, Ziebell M, Waldemar G. Cognitive and functional neuroimaging correlate for anosognosia in mild cognitive impairment and Alzheimer's disease. Int J Geriatr Psychiatry 2005;20:238-246. https://doi.org/10.1002/gps.1272
  15. Roberts RO, Geda YE, Knopman DS, Cha RH, Pankratz VS, Boeve BF, et al. The incidence of MCI differs by subtype and is higher in men The Mayo Clinic Study of Aging. Neurology 2012;78:342-351. https://doi.org/10.1212/WNL.0b013e3182452862
  16. Tierney MC, Szalai JP, Snow WG, Fisher RH. The prediction of Alzheimer disease: the role of patient and informant perceptions of cognitive deficits. Arch Neurol 1996;53:423-427. https://doi.org/10.1001/archneur.1996.00550050053023
  17. Roberts RO, Knopman DS, Mielke MM, Cha RH, Pankratz VS, Christianson TJ, et al. Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. Neurology 2014;82:317-325. https://doi.org/10.1212/WNL.0000000000000055